Abstract | PURPOSE: METHODS: Effect of SFN on levels of different proteins was determined by Western blotting or immunofluorescence microscopy. RNA interference of vimentin and PAI-1 was achieved by transient transfection. Apoptosis was quantified by flow cytometry. Transwell chambers were used to determine cell migration. RESULTS: Exposure of PC-3 and DU145 human prostate cancer cells to SFN resulted in induction of vimentin protein, which was accompanied by down-regulation of E-cadherin protein expression. The SFN-mediated induction of vimentin was also observed in a normal human prostate epithelial cell line. RNA interference of vimentin did not have any appreciable effect on early or late apoptosis resulting from SFN exposure. On the other hand, SFN-mediated inhibition of PC-3 and DU145 cell migration was significantly augmented by knockdown of the vimentin protein. Knockdown of vimentin itself was inhibitory against cell migration. The SFN-treated cells also exhibited induction of PAI-1, which is an endogenous inhibitor of urokinase-type plasminogen activator system. Similar to vimentin, PAI-1 knockdown resulted in a modest augmentation of PC-3 cell migration inhibition by SFN. Tumors from SFN-treated transgenic adenocarcinoma of mouse prostate mice showed a 1.7-fold increase in vimentin protein level compared with control tumors. CONCLUSION: The present study indicates that vimentin and PAI-1 inductions confer modest protection against SFN-mediated inhibition of prostate cancer cell migration.
|
Authors | Avani R Vyas, Shivendra V Singh |
Journal | European journal of nutrition
(Eur J Nutr)
Vol. 53
Issue 3
Pg. 843-52
(Apr 2014)
ISSN: 1436-6215 [Electronic] Germany |
PMID | 24092501
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Anticarcinogenic Agents
- Cadherins
- Isothiocyanates
- Neoplasm Proteins
- Plasminogen Activator Inhibitor 1
- SERPINE1 protein, human
- Sulfoxides
- Vimentin
- sulforaphane
|
Topics |
- Adenocarcinoma
(drug therapy, metabolism, prevention & control)
- Animals
- Anticarcinogenic Agents
(pharmacology, therapeutic use)
- Apoptosis
(drug effects)
- Cadherins
(antagonists & inhibitors, metabolism)
- Cell Line
- Cell Line, Tumor
- Cell Movement
(drug effects)
- Down-Regulation
(drug effects)
- Gene Knockdown Techniques
- Humans
- Isothiocyanates
(pharmacology, therapeutic use)
- Male
- Mice, Transgenic
- Neoplasm Proteins
(agonists, antagonists & inhibitors, genetics, metabolism)
- Plasminogen Activator Inhibitor 1
(agonists, chemistry, genetics, metabolism)
- Prostate
(drug effects, metabolism)
- Prostatic Neoplasms
(drug therapy, metabolism, prevention & control)
- RNA Interference
- Sulfoxides
- Up-Regulation
(drug effects)
- Vimentin
(agonists, antagonists & inhibitors, genetics, metabolism)
|